An international team led by researchers has developed a new technique for identifying gene enhancers in the genomes of humans and other mammals. Called SIF-seq, for site-specific integration fluorescence-activated cell sorting followed by sequencing, this new technique complements existing genomic tools, such as ChIP-seq (chromatin immunoprecipitation followed by sequencing), and offers some additional benefits.
Using only data from an fMRI scan, researchers led by a Yale Univ. undergraduate have accurately reconstructed images of human faces as viewed by other people. The increased level of sophistication of fMRI scans has already enabled scientists to use data from brain scans taken as individuals view scenes and predict whether a subject was, for instance, viewing a beach or city scene, an animal or a building.
Doctors commonly use MRI to diagnose tumors, damage from stroke and many other medical conditions. Neuroscientists also rely on it as a research tool for identifying parts of the brain that carry out different cognitive functions. Now, a team of biological engineers at Massachusetts Institute of Technology is trying to adapt MRI to a much smaller scale.
A new microfluidic method for evaluating drugs commonly used for preventing heart attacks has found that while aspirin can prevent dangerous blood clots in some at-risk patients, it may not be effective in all patients with narrowed arteries. The study, a first in the examination of heart attack prevention drugs, used a device that simulated blood flowing through narrowed coronary arteries to assess effects of anti-clotting drugs.
Researchers in the U.K. have developed a new antibacterial material which has potential for cutting hospital acquired infections. The combination of two simple dyes with nanoscopic particles of gold is deadly to bacteria when activated by light, even under modest indoor lighting. And in a first for this type of substance, it also shows impressive antibacterial properties in total darkness.
AMSBIO has announced the launch of ClioCell, an ex vivo device for removal of dying and dead cells, improving viability and quality of cell populations and their subsequent productivity. The system comprises super-paramagnetic nanoparticles which have been coupled with proprietary elements that bind to dead and dying cells and cell debris.
Women with a faulty breast cancer gene might face a greater chance of rare but deadly uterine tumors despite having their ovaries removed to lower their main cancer risks, doctors are reporting. A study of nearly 300 women with bad BRCA1 genes found four cases of aggressive uterine cancers years after they had preventive surgery to remove their ovaries. That rate is 26 times greater than expected.
Massachusetts Institute of Technology engineers have coaxed bacterial cells to produce biofilms that can incorporate non-living materials, such as gold nanoparticles and quantum dots. These “living materials” combine the advantages of live cells, which respond to their environment and produce complex biological molecules, with the benefits of nonliving materials, which add functions such as conducting electricity or emitting light.
The delicate balance between development of normal tissue and tumors depends in part upon a key molecular switch within cells, Yale School of Medicine researchers report in Science. Their findings reveal a potential mechanism used by cancer cells to recruit healthy cells to promote tumor growth and suggest new strategies to generate healthy tissue.
DNA can already tell us the sex and ancestry of unknown individuals, but now an international team of researchers is beginning to connect genetics with facial features, degrees of femininity and racial admixture. In essence, by including sex and racial admixture, researchers can learn about how certain genes and their variations influence the shape of the face and its features.
In 2007, Massachusetts Institute of Technology scientists developed a type of microscopy that allowed them to detail the interior of a living cell in 3-D, without adding any fluorescent markers or other labels. This technique also revealed key properties, such as the cells’ density. Now the researchers have adapted that method so they can image cells as they flow through a tiny microfluidic channel.
Scientists at Indiana Univ. have unlocked one of the mysteries of modern genetics: how acquired traits can be passed between generations in a process called epigenetic inheritance. The new work finds that cells don’t know to silence some genes based on information hardwired into their DNA sequences, but recognize heritable chemical marks that are added to the genes.
A new strategy for building nanoscale constructs uses the binding properties of complementary strands of DNA to attach nanoparticles to each other. A series of controlled steps builds up a layered thin-film nanostructure. Small-angle x-ray scattering analysis has revealed the precise form that the structures adopted, and points to ways of exercising still greater control over the final arrangement.
When cancers become advanced, tumor cells from the primary tumor can enter the bloodstream and cause metastasis at another organ with deadly effect. While researching the biological implications of CTC spread, Creatv MicroTech researchers found a group of previously unreported cells associated with primary cancer spread. These macrophage-like cells could serve as biomarkers.
Geneticists at the Univ. of California, Davis have decoded the genome sequence for the loblolly pine. The accomplishment is a milestone for genetics because this pine’s genome is massive. Bloated with repetitive sequences, it is seven times larger than the human genome and easily big enough to overwhelm standard genome assembly methods.
A multinational research team led by Duke Medicine scientists has identified a subclass of antibodies associated with an effective immune response to an HIV vaccine. The finding helps explain why a combination of two vaccines was able to show some effect, when one vaccine alone did not. The study also provides key insights that could aid development of new vaccines.
IBM is teaming up with the New York Genome Center to help fight brain cancer. The company said Wednesday that its Watson cloud computing system will be used in partnership with a New York-based genetic research center to help develop treatments for glioblastoma, the most common type of brain cancer in U.S. adults.
A new app developed by researchers the U.K. accurately measures color-based, or colorimetric, tests for use in home, clinical or remote settings, and enables the transmission of medical data from patients directly to health professionals. Called Colorimetrix, the app helps transform any smartphone into a portable medical diagnostic device.
Scientists have revived a moss plant that was frozen beneath the Antarctic ice and seemingly lifeless since the days of Attila the Hun. Dug up from Antarctica, the simple moss was about 1,600 years old, black and looked dead. But when it was thawed in a British lab's incubator, it grew again.
Neuroscientists and bioengineers at Stanford Univ. are working together to solve a mystery: How does nature construct the different types of synapses that connect neurons—the brain cells that monitor nerve impulses, control muscles and form thoughts.
Small protein fragments, also called peptides, are promising as drugs because they can be designed for very specific functions inside living cells. Insulin and the HIV drug Fuzeon are some of the earliest successful examples, and peptide drugs are expected to become a $25 billion market by 2018. However, a major bottleneck has prevented peptide drugs from reaching their full potential.
Duke Univ. engineers have devised a way to improve the efficiency of lithotripsy—the demolition of kidney stones using focused shock waves. After decades of research, all it took was cutting a groove near the perimeter of the shock wave-focusing lens and changing its curvature.
Univ. of Michigan researchers have learned how to fix a cellular structure called the Golgi that mysteriously becomes fragmented in all Alzheimer's patients and appears to be a major cause of the disease. They say that understanding this mechanism helps decode amyloid plaque formation in the brains of Alzheimer's patients, plaques that kills cells and contributes to memory loss and other Alzheimer's symptoms.
Using genome sequencing, National Institutes of Health scientists and their colleagues have tracked the evolution of the antibiotic-resistant bacterium Klebsiella pneumoniae sequence type 258 (ST258), an important agent of hospital-acquired infections. Their results promise to help guide the development of new strategies to diagnose, prevent and treat this emerging public health threat.
Genetically modifying a key protein complex in plants could lead to improved crops for the production of cellulosic biofuels, a Purdue Univ. study says. The researchers generated a mutant Arabidopsis plant whose cell walls can be converted easily into fermentable sugars, but doesn't display the stunted growth patterns of similar mutants.